Macquarie University is a progressive voice among universities in Australia and the Asia Pacific. It was created during a time of extraordinary social transformation to be a different kind of university: it was, and will always be, a bold experiment in higher education.
We have a proud track record of innovation - in teaching, research and community engagement - and have forged a reputation for constantly challenging the conventional thinking of academia. It has a tradition of being untraditional.
Despite - or perhaps because of - its unconventional approach, during its first fifty years, Macquarie University has been consistently ranked as one of the best young universities in the world.
The Centre for the Health Economy is no different.
The Centre is committed to improving the lives of people by providing expert applied research and innovative thinking, independently and responsibly - always.
Provision of expert advice
MUCHE is currently a member of five expert reference panels, including:
- Health economics panel for the federal Department of Health
- Aged care policy development services panel for the federal Department of Health
- Data analysis, Clinical expertise, Productivity and Efficiency, and Performance Measurement panel for the National Health Performance Authority (now incorporated into the Australian Institute of Health & Welfare (AIHW)
- beyondblue Evaluation Services Panel
- Ezetimibe Review Reference Group for the Federal Department of Health
The Centre provides a number of research services to organisations requiring information and applied insights. In addition to macro economic analysis, the Centre is actively involved in a number of projects for industry and government agencies across many field of research.
We use bespoke economic modelling to estimate the actual and potential impacts of change in government policy on the health, ageing and disability care systems, their patients, their carers and the broader community.
We undertake formative, process and impact program evaluations to determine what is achieved by a program, how it can be improved, and the impact of programs on participants and the broader community.
Health technology assessment
We use health economic theory, health state valuation techniques, and simulation modelling to access the efficiency of pharmaceuticals, medical devices, and prosthetics from a government and broader community perspective.
We employ experimental design, stated preference techniques, and choice experiments to estimate the value people place on alternative attributes of health and human service products and services. This is particularly useful in health care where market price is often not available.
We use econometric models to estimate the relationship between health and human service interventions, outcomes, and participant characteristics. Our models allow us to remove potential bias associated with non-randomisation of participants to programs.
We understand economic evaluations of programs and randomised trials to determine whether they are efficient compared to alternative interventions. This includes cost benefit analysis (CBA), cost effectiveness analysis (CEA), and cost utility analysis (CUA).